There is no commercial support for this activity.

About this speaker:

David A. Axelson, MD, is chief of the Department of Psychiatry and Behavioral Health at Nationwide Children's Hospital, chief of the Section of Psychiatry at Nationwide Children's Hospital and the John W. Wolfe Endowed Chair in Pediatric Psychiatry. He is a professor of psychiatry at The Ohio State University School of Medicine and chief of the Division of Child and Adolescent Psychiatry at the Ohio State University Wexner Medical Center.

He received his medical degree from Duke University School of Medicine and completed his residency in child psychiatry at the University of Pittsburgh Medical Center Presbyterian. Dr. Axelson is board certified in child/adolescent psychiatry by the American Board of Psychiatry & Neurology.

Prior to coming to Nationwide Children’s, Dr. Axelson served as the director of the Child and Adolescent Bipolar Services outpatient program at the University of Pittsburgh’s Western Psychiatric Institute and Clinic. He also served as a principal investigator on several National Institute of Mental Health-funded research studies. His research has focused on the phenomenology and treatment of pediatric bipolar disorder.  His treatment research encompasses both psychosocial and psychopharmacological approaches. Dr. Axelson’s phenomenological work has focused on the longitudinal course of pediatric bipolar disorder and the role of subthreshold symptoms of mania in the developmental progression of bipolar disorder.

Disclosure Statements:

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt Health System, and if there will be discussion of any products, services, or off-label uses of product(s) during this presentation.

David A. Axelson, MD reports having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, or off-label uses in this presentation.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, M.D., Briana Riemer, M.D., Sunil Khushalani, M.D., Faith Dickerson, Ph.D., Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Stacey Garnett, RN, MSN, Paul Daugherty, RN, MBA, Heather Billings, RN, and Jennifer Tornabene.